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Salt inducible kinases 2 and 3 
are required for thymic T cell 
development
Meriam Nefla1,2, Nicola J. Darling2, Manuel van Gijsel Bonnello1,2, Philip Cohen2 & 
J. Simon C. Arthur1*
Salt Inducible Kinases (SIKs), of which there are 3 isoforms, are established to play roles in innate 
immunity, metabolic control and neuronal function, but their role in adaptive immunity is unknown. 
To address this gap, we used a combination of SIK knockout and kinase-inactive knock-in mice. The 
combined loss of SIK1 and SIK2 activity did not block T cell development. Conditional knockout of 
SIK3 in haemopoietic cells, driven by a Vav-iCre transgene, resulted in a moderate reduction in the 
numbers of peripheral T cells, but normal B cell numbers. Constitutive knockout of SIK2 combined with 
conditional knockout of SIK3 in the haemopoietic cells resulted in a severe reduction in peripheral T 
cells without reducing B cell number. A similar effect was seen when SIK3 deletion was driven via CD4-
Cre transgene to delete at the DP stage of T cell development. Analysis of the SIK2/3 Vav-iCre mice 
showed that thymocyte number was greatly reduced, but development was not blocked completely 
as indicated by the presence of low numbers CD4 and CD8 single positive cells. SIK2 and SIK3 were 
not required for rearrangement of the TCRβ locus, or for low level cell surface expression of the TCR 
complex on the surface of CD4/CD8 double positive thymocytes. In the absence of both SIK2 and 
SIK3, progression to mature single positive cells was greatly reduced, suggesting a defect in negative 
and/or positive selection in the thymus. In agreement with an effect on negative selection, increased 
apoptosis was seen in thymic TCRbeta high/CD5 positive cells from SIK2/3 knockout mice. Together, 
these results show an important role for SIK2 and SIK3 in thymic T cell development.
T cell development is a tightly regulated process that requires the precise temporal control of genes needed for 
the differentiation of T  cells1–3. Salt Inducible Kinases (SIK) are a group of three protein kinases that have been 
linked to the transcriptional regulation of a number of genes involved in multiple processes including metabolism 
and innate  immunity4–6, but their role in T cell development has not been addressed. SIK1 was first identified 
in the adrenocortical tissues of rats fed on a high salt  diet7 and, together with the closely related SIK2 and SIK3 
isoforms, they form a sub-group of the AMPK-related family of protein kinases (reviewed  in8). SIKs are widely 
expressed, SIK2 and SIK3 being responsible for the great majority of SIK activity in most cell  types9.
In order to be active, SIKs require phosphorylation of their activation loop by the protein kinase LKB1. This 
appears to occur constitutively in most cells, suggesting that SIKs are not activated in vivo via increased phos-
phorylation at this  site10. Consistent with this notion, stimuli have not been identified that increase the intrinsic 
catalytic activity of SIKs, suggesting that regulation may occur at the level of SIK protein expression or via 
stimuli that inhibit SIKs. For example, phosphorylation of SIKs by cyclic AMP-dependent protein kinase (PKA), 
correlates with decreased SIK activity in cells, as judged by the dephosphorylation of SIK  substrates11,12. How 
PKA-mediated phosphorylation decreases SIK activity is not yet fully understood, but it is possible that it may 
promote interaction with 14-3-3 proteins and thereby prevent SIKs from recognising their substrates in  cells12,13.
The first substrates of the SIKs to be identified were members of the cAMP-response element binding pro-
tein (CREB)-regulated transcriptional co-activator (CRTC)  family14. CRTCs bind to the Basic Leucine Zipper 
(bZIP) domain of CREB, thereby promoting the transcription of CREB-dependent immediate early  genes15,16. 
The SIK-catalysed phosphorylation of CRTCs also induces their interaction with 14–3-3 proteins and nuclear 
exit, while dephosphorylation of CRTCs results in their accumulation in the  nucleus14,17,18. For these reasons 
the suppression of SIK activity with small molecule inhibitors induces CRTC dephosphorylation and transloca-
tion to the nucleus where it binds to CREB and promotes the transcription of CREB-dependent  genes9,17. SIKs 
OPEN
1Division of Cell Signalling and Immunology, Wellcome Trust Building, School of Life Sciences, University of 
Dundee, Dundee DD1 5EH, UK. 2MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, 
School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK. *email: j.s.c.arthur@dundee.ac.uk
2
Vol:.(1234567890)
Scientific Reports |        (2021) 11:21550  | https://doi.org/10.1038/s41598-021-00986-0
www.nature.com/scientificreports/
have also been shown to phosphorylate class IIa Histone Deacetylases (HDACs), promoting 14-3-3 binding and 
cytoplasmic  localisation19,20.
In the immune system, the role of SIKs has mainly been studied in the context of innate immune cells and Toll-
Like Receptor (TLR) signalling, where SIK inhibition limits the production of inflammatory  mediators11,17,21–23. 
In macrophages, production of the anti-inflammatory cytokine Interleukin (IL)-10 in response to TLR agonists 
is dependent on the phosphorylation of CREB by Mitogen and Stress-activated Protein Kinase 1 (MSK1) and 
 MSK224–26. TLRs do not directly modify SIK catalytic activity or induce CRTC3 re-localisation to the nucleus. 
However, co-stimulation with TLR agonists and secondary stimuli that activate the cAMP–PKA pathway, such as 
Prostaglandin  E2  (PGE2), blocks SIK-mediated CRTC3  phosphorylation11, promoting CRTC3 dephosphorylation 
and translocation to the nucleus where it acts as a co-activator for CREB on the IL-10 promoter. In addition, SIK 
inhibition promotes the transcription of several other genes linked to potential anti-inflammatory phenotypes 
in macrophages, including Arginase 1 and Sphingosine Kinase  111,17.
The potential roles of SIKs in adaptive immunity have not been addressed, although the SIK substrate CRTC2 
has been reported to be involved in regulating T-helper cell 17 (Th17)  development27. This research showed that 
CRTC2 was not required for T cell development in the thymus, but the ability of CD4 T cells to produce IL-17 
under Th17 polarising conditions was reduced in the absence of CRTC2. In line with this, Th17 numbers were 
reduced in CRTC2 knockout mice relative to wild type animals in experimental autoimmune encephalitis and 
the CRTC2 knockout mice were protected in this  model27. In addition to IL-17, CREB has also been linked to 
the transcription of a number of other genes important in T cells including  CD428,  CD829 and enhancers of T 
cell receptor (TCR)  genes30,31, while CREB is known to be phosphorylated downstream of TCR signaling by 
MSK1/232.
In this paper we have studied how the loss of each SIK isoform or its catalytic activity affects T cell develop-
ment. We report that SIK1 and SIK2 activity are dispensable for normal T cell development, whereas knockout 
of SIK3 results in decreased T cell numbers. The combined knockout of SIK2 and SIK3 results in a severe block 
in thymic T cell development, consistent with a defect in the positive or negative selection of double positive 
thymocytes.
Results
Loss of SIK3 reduces peripheral T cell number in vivo. Previously, we have shown that SIK activity 
is high in the thymus and is predominately due to SIK2 and SIK3 with only a minor input from  SIK19. Consist-
ent with this finding, proteomic studies on peripheral T cells have established that SIK2 and SIK3 are expressed 
in T cells, but have failed to detected  SIK133. Interestingly, in these experiments SIK3 was strongly upregulated 
following T cell receptor (TCR) stimulation, suggesting an important role(s) for SIK3 in T cells (Fig. 1A)33. 
Developing T cells in the thymus undergo a series of stages, starting with Double Negative (DN)  cells34,35. These 
cells then upregulate CD4 and CD8 to become Double Positive (DP) cells, at which point they start to express 
the TCR on their surface before losing expression of either CD4 or CD8 to become Single Positive (SP) cells. 
Analysis of gene expression data in the Immgen  database36 showed that SIK3 mRNA levels increased at the DP 
stage, coinciding with the cell surface expression of the TCR (supplementary Fig. 1). A similar pattern was also 
observed in human T cells in single cell RNAseq data in the Human Cell Atlas (supplementary Fig. 1,37). In 
agreement with this, SIK3 levels were slightly higher in DP cells than DN cells when examined by immunoblot-
ting of sorted thymic subsets (Fig. 1B). We therefore initially assessed the impact of SIK3 knockout on T cell 
development. Both SIK3 knockout and kinase-inactive knock-in mice displayed increased postnatal mortality, 
decreased size at weaning and failure to  thrive9,38. To avoid these adverse phenotypes, a conditional knockout of 
SIK3 was generated using a Vav-iCre transgene to delete SIK3 selectively in the hematopoietic lineage  (SIK3fl/fl/
Vav-iCre+/− mice, supplementary Fig. 2A). These mice were viable and did not exhibit the overt adverse devel-
opmental and welfare issues associated with the total SIK3 kinase-inactive knock-in or knockout mice (data not 
shown). Thymi from  SIK3fl/fl/Vav-iCre+/− mice had similar numbers of Thy1.2+ve T cells compared to wild type 
animals (Fig. 2A). A more detailed analysis of DN, DP and SP cells in the thymi of these mice showed that there 
were no significant differences in the numbers of these subsets between the wild type and  SIK3fl/fl/Vav-iCre+/− 
mice (p > 0.05, two way ANOVA and Sidak’s post hoc testing), although there was a trend to a decrease in the 
numbers of CD4 and CD8 SP cells in the  SIK3fl/fl/Vav-iCre+/− thymi (Fig. 2A). During development in the thy-
mus DN cells can upregulate CD8 slightly before CD4 to give rise to an Intermediate Single Positive (ISP) popu-
lation. To ensure that the presence of ISPs was not obscuring a change in CD8 SP cells in the SIK3 knockout, 
ISPs were excluded by gating on cells with high cell surface TCRβ expression. Analysis of the numbers of TCR 
high CD4 and CD8 SP cells again showed no significant difference between the wild type and  SIK3fl/fl/Vav-iCre+/− 
mice, although the trend for lower numbers of SP cells in the knockout was maintained (supplementary Fig. 3). 
There was however a reduction in the number of  CD3+ve T cells in the spleens of  SIK3fl/fl/Vav-iCre+/− mice rela-
tive to wild type controls (Fig. 2B). In contrast B cell numbers were unaffected by loss of SIK3. The decrease in 
T cells corresponded to a decrease in both the CD4 and CD8 T cell subsets, although this was more pronounced 
for the CD4 cells (Fig. 2C). Similar to the spleen, B cell numbers in the lymph nodes did not differ significantly 
between wild type and  SIK3fl/fl/Vav-iCre+/- mice, but T cell numbers were decreased (Fig. 2D). Again, this cor-
responded to a decrease in both CD4 and CD8 T cells (Fig. 2E). Together, these findings suggest either a reduced 
output of T cells from the thymus in  SIK3fl/fl/Vav-iCre+/− mice or a decreased survival or entry into the secondary 
lymphoid organs. 
The catalytic activity of SIK1 and SIK2 are dispensable for T cell development. Given the above 
findings indicating a role for SIK3 in T cells, we next examined if the related isoforms, SIK1 and SIK2, might 
also regulate T cell development. To examine this, T cells from SIK2  (SIK2ki/ki) and SIK1/2  (SIK1ki/ki/SIK2ki/
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ki) kinase-inactive knock-in mice were analysed. In these mice, the threonine residue in the activation loop of 
SIK1 or SIK2 that is essential for catalytic activity in vitro and in vivo was mutated to  alanine9,10. Analysis of the 
thymi from these mice showed that both  SIK2ki/ki and  SIK1ki/ki/SIK2ki/ki knock-in mice had similar numbers of T 
cells in the thymus compared to wild type controls (Fig. 3A). Analysis of CD4 and CD8 expression in Thy1.2+ve 
thymocytes by flow cytometry showed that the ratios and numbers of DN, DP and SP T cells in the thymus were 
not decreased in the  SIK2ki/ki or  SIK1ki/ki/SIK2ki/ki mice relative to the wild type controls (Fig. 3A). Analysis of the 
spleens from these mice also showed similar numbers of T and B cells in wild type,  SIK2ki/ki and  SIK1ki/ki/SIK2ki/ki 
mice (Fig. 3B), as judged by the expression of CD19 and CD3 to identify B cells and T cells respectively. The ratio 
and numbers of CD4 and CD8 cells in the T cell compartment was also unaffected (Fig. 3C). Similar results were 
obtained in the lymph nodes (Fig. 3D and E).
Deletion of both SIK2 and SIK3 blocks T cell development. While loss of SIK2 did not impact T cell 
development, as T cells express both SIK2 and SIK3 it is possible that compensation can occur between these two 
isoforms. The SIK2/3 double kinase-inactive knock-in results in late embryonic lethality, with the expected Men-
delian frequency of  SIK2ki/ki/SIK3ki/ki observed at E15.59. To look at the effect on T cell development, embryos 
were isolated at E17.5 and their thymi excised and analysed by flow cytometry. This showed that  SIK2ki/ki/SIK3ki/
ki thymi had an increased percentage of DN cells and a decreased percentage of DP cells compared to  SIK2+/ki/
SIK3+/ki thymi (Fig. 4A). There was also an increase in the percentage of cells in the CD8 SP gate. Analysis of 
these cells showed that in the  SIK2ki/ki/SIK3ki/ki thymi, the majority of these cells were TCRβ low, indicating that 
they may represent ISP (immature single positive) cells, an intermediate between the DN and DP cells, rather 
than true CD8 SP cells (Fig. 4B–C). The percentage of CD4 SP cells was also increased, however again none of 
these cells showed high expression of cell surface TCRβ, suggesting they are not true SP cells that have success-
Figure 1.  SIK levels in T cell subsets. (A) Naïve CD4 and CD8 T cells were isolated by FACS and subject to 
TMT labelled proteomic analysis as described  in33. For ex vivo stimulations of the TCR, GP33 (glycoprotein 
amino acids 33–41), 20 ng/ml IL-2 and 2 ng/ml IL-12 were used to stimulate CD8 cells from P14 mice. OVA 
peptide loaded onto antigen presenting cells was used to stimulate CD4 cells from OT-II mice as described  in33. 
Graphs show mean and standard deviation for SIK2 and SIK3. SIK1 was not detected. For CD4 cells, data are 
from independent preparations from 3 mice per genotype and for CD8 cells from 6 mice per genotype. Data is 
derived from Howden et al. 2019, Nat. Immunol. 20, 1542–155433. (B)  Thy1+ve thymocytes pooled from 5 mice 
were sorted based on CD4 and CD8 expression into CD8 single positive, CD4 single positive, double negative 
(DN) and CD4/8 double positive (DP) cells by FACS. 5 μg of lysate was separated by SDS-PAGE and blotted 
using the indicated antibodies. Molecular weight markers are shown, with weights in kDa.
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Figure 2.  SIK3fl/fl/Vav-iCre+/- mice have reduced numbers of T cells in the spleen and lymph nodes. Thymi, spleen and 
lymph nodes were isolated from wild type (WT) and  SIK3fl/fl/Vav-iCre+/- (KO) mice and analysed by flow cytometry. (A) 
Representative CD4 / CD8 plots of Thy1.2+ve cells in the thymus and graphs for absolute numbers of Thy1.2+ve, DN, DP, CD4 
SP and CD8 SP cells. (B) Numbers of  CD3+ve T cells and  CD19+ve B cells in the spleen, along with representative FACS plots. 
(C) Absolute numbers of CD4 and CD8 T cells and representative CD4 / CD8 plots of  CD3+ve cells in the spleen. (D) Numbers 
of  CD3+ve T cells and  CD19+ve B cells in the lymph nodes, along with representative FACS plots. (E) Absolute numbers of 
CD4 and CD8 T cells and representative CD4 / CD8 plots of  CD3+ve T cells in the lymph nodes. Graphs show mean with 
symbols representing measurements from individual mice. Differences between wild type and knockout mice were analysed 
by Student’s t-test for the  Thy1+ve cell graph and by RM two way ANOVA with Sidak’s post hoc testing for the other graphs. 
p < 0.05 is indicated by *, < 0.01 by ** and < 0.001 by ***. Graphs show n = 6 for analysis of thymi, n = 7 or n = 6 for wild type and 
SIK3 knockouts for spleens and n = 6 for wild type and n = 7 for SIK3 knockout lymph nodes.
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Figure 3.  T cell development is not abrogated in  SIK2ki/ki and  SIK1ki/ki /SIK2ki/ki mice. Thymi (A), spleen (B, C) and lymph nodes 
(D, E) were isolated from wild type (WT),  SIK2ki/ki (SIK2) and  SIK1ki/ki/SIK2ki/ki (SIK1/2) mice and analysed by flow cytometry as 
described in the methods. (A) Representative CD4 / CD8 plots of Thy1.2+ve cells in the thymus and graphs for absolute numbers 
of Thy1.2+ve, DN, DP, CD4 SP and CD8 SP cells. (B) Numbers of  CD3+ve T cells and  CD19+ve B cells in the spleen, along with 
representative FACS plots. (C) Absolute numbers of CD4 and CD8 T cells and representative CD4 / CD8 plots of  CD3+ve T cells in the 
spleen. (D) Numbers of  CD3+ve T cells and  CD19+ve B cells in the lymph nodes, along with representative FACS plots. (E) Absolute 
numbers of CD4 and CD8 T cells and representative CD4 / CD8 plots of  CD3+ve cells in the lymph nodes. Graphs show mean with 
symbols representing measurements from individual mice. Differences in cell number between the different genotypes was analysed 
by RM two way ANOVA with Sidak’s post hoc testing except for the number of  Thy1+ve cells in A which was analysed by one way 
ANOVA. p < 0.05 is indicated by *, < 0.01 by ** and < 0.001 by ***. 5  SIK2ki/ki and  SIK1ki/ki /SIK2ki/ki mice were analysed along with 6 
wild type thymi and 7 wild type spleens.
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fully undergone selection (Fig. 4B, D). Together, this suggests that SIK2 and SIK3 activity is required for the 
normal progression of T cells through thymic development.
To examine the effect of the loss of SIK2 and SIK3 in the adult thymus, the conditional SIK3 knockout mice 
were bred to total SIK2 knockout mice and then onto mice carrying a Vav-iCre transgene. The resulting  SIK2-/-/
SIK3fl/fl/Vav-iCre+/- mice lack SIK2 in all cells and SIK3 only in hematopoietic cells. Immunoblotting confirmed 
the absence of both SIK2 and SIK3 in splenocytes from these mice (supplementary Fig. 2B).
Figure 4.  Embryonic T cells in  SIK2ki/ki/SIK3ki/ki mice have a defect in cell surface TCRβ upregulation. Thymi 
were isolated from embryonic day 17.5 embryos and analysed by flow cytometry for Thy1, CD4, CD8 and 
TCRβ. Graphs show percentage of DN, DP and SP cells in in Thy1.2+ve thymocytes from 2  SIK2ki/ki/SIK3ki/ki 
and 4  SIK2+/ki/SIK3+/ki littermate controls (A) and representative plots are shown in (B). Cell surface staining 
of TCRβ in CD8 single positive (C) and CD4 single positive (D) thymocytes are also shown. Differences in cell 
number between the different genotypes was analysed by RM two way ANOVA with Sidak’s post hoc testing. 
p < 0.01 is indicated by ** and < 0.001 by ***.
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Analysis of the thymi from  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice showed that there was a major decrease in thymo-
cyte number (Fig. 5A). This corresponded to a decrease in the DN, DP and SP subsets (Fig. 5A). Previous studies 
have not shown a major effect of the Vav-iCre transgene on T cell development, and consistent with the effect 
seen in Fig. 5A being due to loss of SIK2 and SIK3, a similar drop was not seen in the  SIK3fl/fl/Vav-iCre+/− mice 
(see Fig. 2A). To confirm this, a combination of  Cre+ve and  Cre−ve mice that were wild type for SIK2 and SIK3 
were analysed in these experiments. Comparison of these showed that the Vav-iCre transgene was not affect-
ing the numbers of T cell subsets in the thymus (supplementary Fig. 2C). In line with the decreased thymocyte 
number, the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice had greatly reduced numbers of T cells in their spleen (Fig. 5B), 
which was due to a low number of both CD4 and CD8 T cells (Fig. 5C). Analysis of CD44 and CD62L in the 
splenic T cells showed that both the CD4 and CD8 cells were enriched in  CD44+ve/CD62L−ve cells in  SIK2-/-/
SIK3fl/fl/Vav-iCre+/− mice (Fig. 5D), suggesting an activated phenotype. This may reflect expansion in the periph-
ery due to the low number of T cells exiting the thymus. Similar results were obtained in the lymph nodes with 
lower numbers of both CD4 and CD8 cells being present. As in the spleen, the remaining T cells were enriched 
in  CD44+ve/CD62L−ve cells (Supplementary Fig. 4). In addition to the number of αβ T cells being reduced, the 
numbers of γδ T cells were also lower in  SIK2-/-/SIK3fl/fl/Vav-iCre+/− mice (supplementary Fig. 5). In contrast to 
the effect on T cells, SIK2/3 knockout did not reduce the total numbers of B cells in the spleen or lymph nodes 
(supplementary Fig. 6). Follicular B cells make up the majority of the B cells in the spleen and the numbers of 
these cells was not reduced in the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice, although there was a trend for a decrease in 
marginal zone B cells this did not reach significance (p > 0.05, supplementary Fig. 6).
As the  SIK2−/−/SIK3fl/fl/Vav-iCre+/− mice had reduced DN T cells in the thymus, development of DN cells was 
examined to determine if SIK2 and SIK3 affected the progression of these cells through development. DN cells 
can be divided into several stages, DN1 to DN4, based on their expression of CD25 and CD44. The ratios of the 
different DN subsets were similar between wild type and the  SIK2−/−/SIK3fl/fl/Vav-iCre+/− mice (Fig. 6A), although 
the absolute numbers were reduced in the  SIK2−/−/SIK3fl/fl/Vav-iCre+/− mice (Fig. 6A). Cells progressing from 
DN3 to DN4 undergo a process referred to as β-selection, which requires a productive VDJ recombination event 
at the TCRβ locus and association of the expressed TCRβ chain with pre-Tα to form a pre-TCR 34,35. Analysis of 
intracellular levels of the TCRβ chain by flow cytometry showed that  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice exhibited 
increased TCRβ levels in DN3 cells relative to  SIK2+/+/SIK3+/+/Vav-iCre+/- controls (Fig. 6B). Signalling down-
stream of the pre-TCR leads to the upregulation of CD2 and CD5 in DN4 cells relative to DN3  cells39,40. Similar 
to wild type DN cells, the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- DN4 cells expressed higher levels of CD2 and CD5 than 
DN3 cells (Fig. 6B), indicating that the loss of SIK2 and SIK3 did not prevent the formation of a functional pre-
TCR. Interestingly,  SIK2-/-/SIK3fl/fl/Vav-iCre+/- DN3 cells expressed higher levels of CD2 and CD5 than wild type 
DN3 cells, possibly reflecting the higher expression of intracellular TCRβ in the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- cells 
(Fig. 6B). Taken together, this data indicated that the loss of SIK2 and SIK3 does not prevent the formation of 
a functional pre-TCR, although the timing of β-selection may be earlier in the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- cells. 
 SIK2-/-/SIK3fl/fl/Vav-iCre+/- thymi had an atypical population that was CD8 negative but intermediate for CD4 
and not present in the wild type mice (Fig. 5A). The expression of CD2, CD5, CD25, CD44 and intracellular 
TCRβ was also examined in these cells (supplementary Fig. 7). These cells were  CD44-ve and had variable levels 
of CD25. They also expressed intracellular TCRβ but low levels of cell surface TCRβ. In addition, they expressed 
CD2 and CD5. Together, these results suggested that they were derived from DN3/4 cells that had undergone 
rearrangement of the TCRβ chain (supplementary Fig. 7). When these cells were included in an extended double 
negative gate, the numbers of DN3 and DN4 cells were similar between  SIK2-/-/SIK3fl/fl/Vav-iCre+/- and wild type 
mice, although DN1 and DN2 cells were still lower (supplementary Fig. 7).
Following progression to the DP stage, cells rearrange their TCRα gene and start to express a mature TCR 
on their cell  surface34,35. These DP cells then undergo positive and negative selection to remove cells with either 
non-functional or self-reactive T cell receptors. Cells passing selection further upregulate their cell surface TCR 
levels and transition to SP cells. Notably the fraction of TCR high cells in the thymus was markedly reduced in 
 SIK2-/-/SIK3fl/fl/Vav-iCre+/- thymi (Fig. 6C). As expected, the majority of the TCR high cells in wild type thymi 
corresponded to SP cells (Fig. 6D). In  SIK2-/-/SIK3fl/fl/Vav-iCre+/- thymi, the TCR high cells were also mainly SP 
cells, but their numbers were greatly reduced (Fig. 6D). Although  SIK2-/-/SIK3fl/fl/Vav-iCre+/- DP cells were able 
to express low levels of TCR on their cell surface, analysis of total CD4 and CD8 SP cells showed that a much 
lower percentage of cells were TCR high in  SIK2-/-/SIK3fl/fl/Vav-iCre+/- relative to wild type thymi (Fig. 6E). In 
addition to low expression of cell surface TCR, a large proportion of  SIK2-/-/SIK3fl/fl/Vav-iCre+/- CD4 cells also 
did not express CD5 (Fig. 6F). Levels of cell surface TCRβ and CD5 can be used to identify activated cells that 
could be undergoing negative selection. Staining for cleaved caspase 3, which marks cells entering apoptosis has 
been reported to provide an indication of the numbers of cells undergoing clonal deletion in this  population41. 
In the activated T cell population,  SIK2-/-/SIK3fl/fl/Vav-iCre+/− T cells showed an increased percentage of cells 
positive for cleaved caspase 3 compared to wild type cells, suggesting that there were increased numbers of T 
cells undergoing clonal deletion during negative selection (Fig. 7). In contrast, the percentage of cells staining 
positive for cleaved caspase 3 in the TCRβlow gate, where cells may be undergoing positive selection and dying 
by neglect, was similar between the two genotypes (Fig. 7).
The above data indicated that in the absence of SIK2 and SIK3, cells cannot progress effectively from DP to 
SP cells. Vav-iCre however deletes early in haemopoietic development and it is possible that this phenotype is 
not due to an acute phenotype in DP cells, but a carry-over from issues earlier in T cell development. To further 
examine the role that SIK2 and SIK3 play in the progression from DP to SP cells, the  SIK2-/-/SIK3fl/fl mice were 
crossed with a CD4-Cre transgenic mouse to delete SIK3 at the DP stage of T cell development. The  SIK2-/-/
SIK3fl/fl/CD4-Cre+/- mice had similar thymocyte numbers to wild type controls and numbers of DN and DP cells 
were not decreased in the knockout (Fig. 8A). In contrast, both CD4 and CD8 SP cell numbers were decreased 
in the  SIK2−/−/SIK3fl/fl/CD4-Cre+/− thymi relative to wild type controls (Fig. 8A). Similar to the  SIK2−/−/SIK3fl/fl/
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Vav-iCre+/− mice, in the  SIK2−/−/SIK3fl/fl/CD4-Cre+/− thymi the numbers of TCRβ high cells was lower than in 
wild type thymi, as was the numbers of CD4 and CD8 TCRβ high single positive cells (Figs. 8B, C). Again, similar 
to  SIK2-/-/SIK3fl/fl/Vav-iCre+/- SP cells, the proportion of  SIK2−/−/SIK3fl/fl/CD4-Cre+/− SP cells expressing high 
levels of surface TCR was lower than for wild type cells (Fig. 8D). In addition, for those cells that were TCRβ 
high, the intensity of staining was lower in  SIK2−/−/SIK3fl/fl/CD4-Cre+/- SP cells compare to wild type cells. A 
proportion of the  SIK2-/-/SIK3fl/fl/CD4-Cre+/- CD4 SP cells also expressed low levels of CD5, but this was not as 
pronounced as in the  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice (compare Figs. 6F and 8D).
In line with the decrease in SP cells in the thymus, the spleens of  SIK2-/-/SIK3fl/fl/CD4-Cre+/− mice had lower 
numbers of T cells (Fig. 9A). This drop was more pronounced for the CD4 T cells relative to the CD8 T cells in 
the spleen (Fig. 9B). Analysis of CD44 and CD62L expression showed that the  SIK2-/-/SIK3fl/fl/CD4-Cre+/- CD4 
cells were enriched in  CD44+ve/CD62L−ve cells (Fig. 9C), although this was not as pronounced as in the  SIK2-/-/
SIK3fl/fl/Vav-iCre+/- mice (compare Figs. 9C and 5D). Similar results were obtained for expression of CD44 and 
CD62L in  SIK2-/-/SIK3fl/fl/CD4-Cre+/- and wild type CD8 T cells in the spleen (Fig. 9C) or when T cells were 
analysed in the lymph nodes of  SIK2-/-/SIK3fl/fl/CD4-Cre+/- mice (Supplementary Fig. 8).
CD4+ve/CD25+ve/FOXP3+ve cells (Tregs) are an important immunosuppressive T cell  subset42. Analysis of 
CD4 cells in the thymus, spleen and lymph nodes of  SIK2-/-/SIK3fl/fl/CD4-Cre+/- mice revealed that an increased 
percentage of the CD4 T cells in the spleen and lymph nodes were Tregs relative to wild type mice (Fig. 10). 
Despite this, due to the reduced numbers of CD4 T cells in the mice, the absolute numbers of Tregs were lower in 
the thymus, spleen and lymph nodes of  SIK2−/−/SIK3fl/fl/CD4-Cre+/− relative to wild type mice (Fig. 10). Similar 
results were obtained in  SIK2−/−/SIK3fl/fl/Vav-iCre+/− mice (supplementary Fig. 9).
Discussion
The results presented in this paper show that SIK2 and SIK3 have an important role in T cell development. 
Loss of SIK2 kinase activity alone had little impact on T cell development while loss of SIK3 caused a modest 
reduction in thymocyte and peripheral T cell numbers. A combined loss of SIK2 and SIK3, however, resulted in 
a large reduction in T cells in the spleen and lymph nodes and a failure of T cell differentiation in the thymus. 
This suggests that SIK2 and SIK3 are the major functional SIK isoforms in T cells and that SIK2 can partially 
compensate for the loss of SIK3. In this study, two Cre transgenes were used to study SIK function in T cells. 
Vav-iCre, which deletes within immune progenitors prior to the entry of cells into the thymus, and CD4-Cre 
which deletes at the DP stage of thymic development. As would be expected, deletion via CD4-Cre had a less 
pronounced effect on early T cell development in the thymus, but did reduce the progression of DP cells to CD4 
and CD8 SP cells. Deletion using either Vav-iCre or CD4-Cre resulted in a reduction of TCRβhi DP cells and a 
decreased progression of cells to the SP stage. The greatly reduced numbers of TCRβhi CD4 and CD8 SP cells 
in these mice could indicate an increased rate of clonal deletion during negative selection. Consistent with this 
 SIK2-/-/SIK3fl/fl/Vav-iCre+/- TCRβhi/CD5+ve cells, which are likely to be undergoing selection, showed a higher rate 
of apoptosis than the equivalent wild type population. This does not however exclude the possibility that SIKs 
may also play additional roles in positive selection.  SIK2−/−/SIK3fl/fl/Vav-iCre+/− mice also showed a reduction 
in the numbers of DP cells, potentially suggesting that SIK2 and SIK3 play a role earlier in T cell development, 
in addition to their effects on the DP to SP transition. One reason for a block in thymic development can be a 
failure to rearrange the TCRβ or TCRα locus at the DN3 and DP stage of development. Loss of SIK2 and SIK3 
however did not prevent TCR chain rearrangement, as evidenced by expression of an intracellular TCRβ chain 
in DN3 and DN4 cells, as well as the upregulation of CD2 and CD5 in DN4 cells. In fact, loss of SIK2 and SIK3 
resulted in a higher expression of intracellular TCRβ in DN3 cells, suggesting that TCRβ rearrangement might 
be promoted rather than inhibited by deletion of SIK2 and SIK3. Furthermore, the initial low-level expression of 
TCR on the surface of DP cells was unaffected by loss of SIK2 and SIK3, suggesting that TCRα chain rearrange-
ment was able to occur. It is however possible that, as discussed below, the loss of SIK2 and SIK3 may affect TCR 
chain diversity following VDJ recombination.
The molecular mechanism by which SIK2 and SIK3 regulate T cell development requires further study. For 
SIKs to be active, they must be constitutively phosphorylated by  LKB110. Conditional knockout of LKB1 early 
in T cell development using Lck-Cre did not prevent expression of the pre-TCR but did block progression from 
DN to DP  cells43. In addition to SIKs, LKB1 is also necessary for the activity of a number of other members of the 
Figure 5.  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice show abnormal T cell development. (A) Thymi were isolated from 
wild type (WT) and  SIK2-/-/SIK3fl/fl/Vav-iCre+/- (KO) mice and analysed by flow cytometry. Data show the 
number of Thy1.2+ve cells in the thymus, representative CD4/CD8 flow cytometry plots of Thy1.2+ve cells in the 
thymus and the numbers of DN, DP, CD4 SP and CD8 SP cells. (B–D) Splenocytes were isolated from wild 
type (WT) and  SIK2-/-/SIK3fl/fl/Vav-iCre+/- (KO) mice and analysed by flow cytometry following lysis of red 
blood cells. Single cell suspensions were analysed for expression of CD3, CD4, CD8, CD44 and CD62L. Total 
cell numbers and numbers of  CD3+ve T cells in the spleen, along with representative FACS plots are shown in 
(B). Absolute numbers of CD4 and CD8 T cells along with representative CD4/CD8 plots of  CD3+ve T cells 
are shown in (C). The expression of CD44 and CD62L was also examined in both  CD3+ve/CD4+ve and  CD3+ve/
CD8+ve T cells and the data shows representative flow cytometry plots and the percentage of  CD44+ve/CD62L-ve 
and  CD44-ve/CD62L+ve cells (D). Graphs show mean with symbols representing measurements from individual 
mice. Differences in cell number between wild type and knockout mice were analysed by Student’s t-test (B and 
 Thy1+ve cells in A) or RM two way ANOVA with Sidak’s post hoc testing in all other graphs. p < 0.05 is indicated 
by *, < 0.01 by ** and < 0.001 by ***. For the thymus 11 WT and 12 knockout mice were analysed while for the 
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Figure 6.  Thymic T cell development is compromised in  SIK2-/-/SIK3fl/fl/Vav-iCre+/- mice. Thymi were 
isolated from wild type (WT) and  SIK2-/-/SIK3fl/fl/Vav-iCre+/- (KO) mice and analysed by flow cytometry. To 
identify DN cell subsets, Thy1.2+ve  CD4-ve  CD8-ve cells were gated and analysed for CD25 and CD44 expression. 
Representative FACS plots and absolute numbers of the different DN subsets (n = 11 for WT and n = 12 for 
knockouts) are shown in (A). Intracellular staining for TCRβ and cell surface expression of CD2 and CD5 in 
DN3 (Thy1.2+ve  CD4−ve  CD8−ve  CD44−ve  CD25+ve) and DN4 (Thy1.2+ve  CD4−ve  CD8−ve  CD44−ve  CD25−ve) cells 
is shown in (B). Thymocytes were also analysed for expression of cell surface TCRβ. Representative plots of 
Thy1.2 vs TCRβ in live thymocytes along with quantification of TCRβhigh cells is shown in (C). Analysis of CD4 
and CD8 expression in the TCRβhigh cells is shown in (D). For C and D, n = 7 for WT and n = 8 for knockouts. 
Representative histograms for cell surface expression of TCRβ and CD5 in DP, CD4 and CD8 SP cells are shown 
in (E and F). Graphs show mean with symbols representing measurements from individual mice. Differences 
in cell number between wild type and knockout mice were analysed by Student’s t-test. p < 0.05 is indicated by 
*, < 0.01 by ** and < 0.001 by ***.
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AMPK family of protein kinases, which could explain the earlier block observed upon loss of LKB1 compared to 
loss of SIK2 and SIK3. Knockout of LKB1 driven via CD4-Cre resulted in cells that failed to progress efficiently 
from DP to SP  cells44, similar to what was observed for double knockout of SIK2 and SIK3 in this study. SIKs are 
Figure 7.  Loss of SIK2 and SIK3 resulted in increased apoptosis in cells undergoing negative selection. Thymi 
were isolated from wild type and  SIK2−/−/SIK3fl/fl/Vav-iCre+/− (KO) mice and stained for CD4, CD8, TCRβ, 
CD5 and cleaved caspase 3. Gating on expression of CD4 and/or CD8 was used to identify cells at the DP or 
SP stage of development. Cells were then gated based on TCRβ and CD5 to identify activated cells that may 
be undergoing negative selection or DP cells that were TCRβlow and may be undergoing positive selection. The 
percentage of cells positive for cleaved caspase 3 was then determined in these gates. Representative gating is 
shown in (A), and quantification of 4 mice per genotype in (B). Data was analysed by RM two way ANOVA and 
Sidak’s post hoc testing with ** indicating a p value < 0.01.
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Figure 8.  Transition to CD4 and CD8 SP cells is reduced in  SIK2−/−/SIK3fl/fl/CD4-Cre+/− mice. Thymi were 
isolated from wild type (WT) and  SIK2-/-/SIK3fl/fl/CD4-Cre+/- (KO) mice and analysed by flow cytometry. The 
number of Thy1.2+ve cells in the thymus along with representative CD4/CD8 plots and numbers of DN, DP and 
SP cells is shown in (A). Thymocytes were also analysed for expression of cell surface TCRβ. Representative 
plots of Thy1.2 vs TCRβ in live thymocytes along with quantification of TCRβhigh cells is shown in (B). Analysis 
of CD4 and CD8 expression in the TCRβhigh cells is shown in (C). Representative histograms for cell surface 
expression of TCRβ and CD5 in DP, CD4 and CD8 SP cells are shown in (D). Graphs show mean with symbols 
representing measurements from individual mice. Differences in cell number between wild type and knockout 
mice were analysed by two tailed Student’s t-test (A, B) or two way ANOVA with Sidak’s post hoc testing. 
p < 0.05 is indicated by *, < 0.01 by ** and < 0.001 by ***. Graphs show data for 7 mice per genotype.
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Figure 9.  T cell profiles in the spleen of  SIK2−/−/SIK3fl/fl/CD4-Cre+/- mice. Splenocytes were isolated from wild 
type (WT) and  SIK2−/−/SIK3fl/fl/CD4-Cre+/- (KO) mice and analysed by flow cytometry following lysis of red 
blood cells. Single cell suspensions were analysed for expression of CD3, CD4, CD8, CD44 and CD62L. A subset 
of mice were also stained for CD19 to identify B cells. Numbers of  CD3+ve T cells and  CD19+ve B cells in the 
spleen, along with representative FACS plots are shown in (A). Absolute numbers of CD4 and CD8 T cells along 
with representative CD4/CD8 plots of  CD3+ve T cells are shown in (B). The expression of CD44 and CD62L was 
also examined in both  CD3+ve/CD4+ve and  CD3+ve/CD8+ve T cells and data shows representative flow cytometry 
plots of the percentage of  CD44+ve/CD62L-ve and  CD44-ve/CD62L+ve cells (C). Graphs show mean and standard 
deviation and with symbols representing measurements from individual mice (8 mice per genotype for T cells 
and 4 mice per genotype for B cells). Differences in cell number between wild type and knockout mice were 
analysed by two tailed Student’s t-test in (A) and RM two way ANOVA and Sidak’s post hoc testing in (B) and 
(C). p < 0.05 is indicated by *, < 0.01 by ** and < 0.001 by ***.
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able to phosphorylate CRTCs and thus inhibit their ability to function as co-activator proteins for CREB. The 
effect of CRTC1 and CRTC3 knockout on T cells has not been reported, while CRTC2 is required for the efficient 
generation of Th17 cells but not for T cell development in the  thymus27. At present, the only established target 
for CRTCs is the transcription factor CREB, which can be activated by phosphorylation on Ser133 and/or by the 
recruitment of CRTCs to its bZIP domain. However, CREB function is not essential for T cell development in 
adult mice. Conditional knockout of CREB using Lck-Cre in mice lacking ATF1 (a transcription factor closely 
related to CREB) has been reported. This demonstrated that lack of CREB and ATF1 did not block thymic T cell 
development although there was a decrease in thymocyte number in the double knockout  mice45. Significantly, 
CD2, CD5 and TCRβ expression were normal and T cells were present in the periphery, in contrast to the SIK2/
SIK3 double knockout mice studied here. Blocking TCR-induced CREB phosphorylation, either via knockout of 
both MSK1 and  MSK232 or by mutation of the codon for Ser133 in the CREB gene (unpublished observations) 
also does not suppress T cell development in adult mice. However, it is noteworthy that CREB has been reported 
to be required for normal development of the embryonic thymus. The knockout of CREB reduced the number 
of TCRβhigh  cells46, while overexpression of ICER (an inhibitor of CREB mediated transcription) decreased cell 
Figure 10.  Analysis of Tregs in  SIK2-/-/SIK3fl/fl/CD4-Cre+/- mice. Thymi, spleen and lymph nodes were isolated 
from wild type (WT) and  SIK2−/−/SIK3fl/fl/CD4-Cre+/− (KO) mice. Cells were stained for TCRβ, CD4, CD25 
and FoxP3. Tregs were identified as TCRβ+ve/CD4+ve/CD25+ve/FoxP3+ve cells. Representative CD25 / FoxP3 
plots of live gated TCRβ+ve/CD4+ve cells are shown along with absolute numbers of Tregs are shown for thymus 
(A), spleen (B) and lymph nodes (C). Differences in cell number between wild type and knockout mice were 
analysed by Student’s t-test. p < 0.01 by ** and < 0.001 by ***. Data show results from 6 wild type and 8 knockout 
mice for the thymus and spleen and 4 wild type and 7 knockout mice for the lymph nodes.
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number and delayed progression to DP cells in foetal thymic organ  cultures47. In our model, the loss of both SIK2 
and SIK3 would be expected to increase rather than block the induction of CREB-dependent genes so it is pos-
sible that some of the observed phenotype arises from an increased activation of CREB in developing thymocytes.
Another set of substrates for SIKs are class IIa HDACs, a family that includes HDACs 4, 5, 7 and 9. The indi-
vidual knockout of HDAC4 or HDAC5 does not compromise thymic T cell development, although  HDAC5-/- 
Tregs were reported to have less suppressive  activity48,49. A detailed analysis of HDAC9 deficiency has not been 
published, but  HDAC9-/- mice do have peripheral T  cells50. HDAC9 is, however, important in Tregs and  HDAC9-/- 
Tregs show enhanced suppressive activity relative to wild type  Tregs50. HDAC7 is highly expressed in the  thymus51 
and like SIK3 is upregulated as cells progress to the DP stage of development (supplementary Fig. 1). Conditional 
knockout of HDAC7 driven via Lck-Cre results in a strong reduction of CD4 and CD8 SP cells in the thymus 
along with a more moderate reduction in DP cells. This was attributed to increased apoptosis of the  HDAC7-/- 
cells, resulting in a failure to establish a full repertoire of TCRα rearrangements leading to impaired positive 
 selection52. This has parallels to the SIK2/3 phenotype reported here, although loss of SIK2 and SIK3 results in 
a stronger reduction in DP cells than in the HDAC7 knockout. SIKs target multiple class IIa HDACs and it is 
possible that different class IIa HDACs may compensate for each other. Therefore, knockout of multiple HDAC 
isoforms may give a more severe thymic phenotype. It should also be noted that the phosphorylation of class 
IIa HDACs by SIKs affects HDAC localisation, but does not necessarily inhibit HDAC function. Thus Ser to Ala 
knock-in mutations of the sites in class IIa HDACs phosphorylated by SIKs would be required to determine if 
HDACs were the primary substrate downstream of SIKs in regulating T cell development, or if SIKs also target 
other substrates in T cells.
In summary we show here that loss of SIK3 results in lower numbers of T cells in secondary lymphoid organs 
and that combined loss of SIK2 and SIK3 inhibits T cell development in the thymus.
Methods
Mice. The generation of kinase-inactive SIK1  (SIK1ki/ki; gene symbol  SIK1tm1.1Arte), SIK2  (SIK2ki/ki; gene sym-
bol  SIK2tm1.1Arte) and SIK3  (SIK3ki/ki; gene symbol  SIK3tm1.1Arte) knock-in mice as well as the CD4-Cre and Vav-
iCre transgenic mice have been described  previously9,53,54. Neither of these two Cre strains was found to have 
a major impact on thymic T cell development in previous  studies55. The SIK2 knock-in has LoxP sites around 
exons 5 to 7 in SIK2 (which contains the T175A mutation in the activation loop of the kinase domain, abolish-
ing kinase activity). To generate SIK2 knockout mice, the SIK2 knock-in mice were crossed to the Cre Deleter 
strain (C57BL/6-Gt(ROSA)26Sortm16(cre)Arte, Taconic Biosciences). The resulting SIK2 knockout allele lacks the 
sequence corresponding to amino acids 160 to 316 in the kinase domain of SIK2 and has a frame shift mutation 
from exon 4 to 8. These mice were bred away from the Cre transgene.
To generate a conditional SIK3 allele, C57BL/6 N-Atm1Brd  Sik3tm1a(EUCOMM)Hmgu/Wtsi
mice were obtained from the European Mouse Mutant Archive (EMMA) repository. These mice were crossed 
to Flpe transgenic mice (Taconic Biosciences) to remove the LacZ and selection cassettes, resulting in an allele 
 (SIK3fl) with LoxP sites on either side of exon 5. This exon encodes residues 226 to 247 of SIK3 which includes 
the DFG motif of the kinase domain that is essential for catalytic activity (Supplementary Fig. 2A). Removal of 
exon 5 would also result in a frame shift mutation from exon 4 to 6.
Both SIK2 and SIK3 are located on chromosome 9 separated by approximately 4.6 Mb. To generate the 
SIK2/3 double knockout,  SIK2-/- and  SIK3fl/fl mice were crossed. The resulting  SIK2+/-/SIK3+/fl mice were crossed 
to  SIK3fl/fl mice until an  SIK2+/-/SIK3fl/fl mouse was obtained, which would be indicative of a crossover event 
occurring to generate mice with the mutant SIK2 and SIK3 alleles on the same chromosome.
All lines were maintained by backcrossing with wild type C57Bl6/J mice obtained from Charles River Labora-
tories UK. The mice were housed in individually ventilated cages at 21 °C, 45–55% humidity, and a 12/12-h light/
dark cycle. The mice were provided with free access to food (R&M3) and water and kept under specific pathogen-
free conditions. Mice were culled via a rising concentration of  CO2 and death confirmed by cervical dislocation.
This work was performed under a UK Home Office Project Licence in accordance with UK and EU regula-
tions and approved by the University of Dundee Ethical Review Committee and in line with ARRIVE guidelines.
Mice were genotyped from ear biopsies by PCR. Protocols for genotyping the SIK kinase-inactive knock-in 
mice were as  reported9. Routine genotyping of the SIK2 knockout mice was carried out using the primers AAG 
AGA GTG TGG GAC TAA CTTGG, CTT AAA AGC TGG GCA TAG TGG and TGT TCT CTA AGC ATG CTA ACT 
ACT AGG, which gives a 395 bp band for a wild type allele and a 557 bp band for a knockout allele. For the con-
ditional SIK3 line, GCT GAA GAC GTG GTG TGG CAG and GCA GGT AAC ATT TCT GCT TCC AGA C were used 
which give a 377 bp band and 457 bp band for wild type and floxed alleles respectively. For the Vav-iCre mice the 
primers CTC CAA CCT GCT GAC TGT GC and CAC CAG GGA CAC AGC ATT GG were used which gives a 350 bp 
band for  Cre+ve animals. For the CD4-Cre mice the primers CAG ATT CCC AAC CAA CAA GAG CTC AAGG and 
CCC AAA TGT TGC TGG ATA GTT TTT ACT GCC were used which gives a 333 bp band for  Cre+ve animals, along-
side AAA GTC GCT CTG AGT TGT TAT and GGA GCG GGA GAA ATG GAT ATG to give a 602 bp control band.
To maintain Cre lines as heterozygous animals, male and female  Cre+ve mice were not bred together. Due to 
the possibility of germline deletion in male Vav-iCre+ve mice, Vav-iCre+ve males were not used for  breeding56. 
 SIK3fl/fl/Vav-iCre+/− female mice showed greatly reduced fertility and so  SIK3+/fl/Vav-iCre+/− mice were used for 
breeding.
Flow cytometry. The thymus, spleen and lymph nodes were dissected from wild type and transgenic mice 
and cells were isolated by pressing the corresponding tissue through a 40 μm EASYstrainer (Greiner Bio-One). 
For spleens, red blood cells in the resulting cell suspensions were removed using Red Blood Cell Lysing Buffer 
(Sigma), after which cells were washed and resuspended in FACS buffer (PBS, 1% (w/v) BSA). Viable cells from 
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different tissues were then counted after addition of DAPI (1.25 μg/mL; BioLegend). Cells were counted on a 
BD FACSVerse.
To avoid non-specific binding of antibodies to Fc receptors, between 2 and 4 ×  106 cells were blocked with 
rat anti-mouse CD16/CD32 Fc block (clone 2.4G2; BD Pharmingen; 1:50 in FACS buffer) for 20 min at 4 °C. 
Cells were then stained with fluorophore-conjugated antibodies to the required antigens. The antibodies used 
are listed in Table 1. Flow cytometry data was acquired on a BD FACSCanto II and analysed using FlowJo Ver-
sion 10 software. Live lymphocytes were gated based on SSC-A and FSC-A and then doublets excluded based 
on FSC-W / FSC-A plots. For all experiments except the analysis of CD44 and CD62L and cleaved caspase 3, 
live cells were then gated based on DAPI exclusion.
For intracellular TCRβ staining, cells were isolated from the thymus as described above. Thymocytes were 
stained for cell surface markers (with anti-Thy1.2, anti-CD4, anti-CD8, anti-CD44 and anti-CD25) to determine 
Double Negative (DN) 3 and DN4 cell populations. Cells were then fixed using fixation buffer (eBiosciences) 
for 20 min at 4 °C, washed with FACS buffer, permeabilized for 20 min at 4 °C in 1 X permeabilization buffer 
(eBiosciences) and washed with FACS buffer. Cells were then incubated with 1:50 Fc block made up in 1 X per-
meabilization buffer for 10 min at 4 °C, washed with FACS buffer, and incubated with 1:50 anti-TCRβ antibody 
made up in 1X permeabilization buffer for 30 min at 4 °C. For staining of Foxp3, the Foxp3/Transcription factor 
staining buffer set (00–5523-00) from eBioscience was used according to the manufacturer’s instructions. Cleaved 
caspase 3 was assessed as detailed  previously41.
To analyse embryonic T cells, matings were checked daily for plugs and embryos isolated at E17.5. The embry-
onic thymus was isolated and cells stained for Thy1.2, TCRβ, CD4 and CD8 and analysed by flow cytometry as 
described above. A sample of tissue was retained from each embryo and used for genotyping.
Immunoblotting. Splenocytes were isolated as above and, following removal of red blood cells, they were 
lysed as  described9. Cell extracts were clarified by centrifugation and protein concentrations determined using 
the Bradford assay. 5 (Fig. 1) or 25 (Supplementary Fig. 2) μg of protein extract was separated by SDS-PAGE 
and immunoblotted using antibodies described  previously9. The SIK2 and SIK3 antibodies were obtained from 
MRC PPU Reagents and Services (https:// mrcpp ureag ents. dundee. ac. uk)9 and detected using a horseradish per-
oxidase-conjugated anti-sheep IgG secondary antibody (Abcam). Class IIa HDAC, p38 and GAPDH antibodies 
were from Cell Signaling Technology and the CRTC3 antibody (clone EPR3440) was from Abcam. The expres-
sion of proteins was visualized using a Chemidoc MP imaging system (Bio-Rad Laboratories) or Li-Cor Odyssey 
Fc following addition of an enhanced chemiluminescence substrate (Amersham).
Statistical analysis. Numerical data was compiled and processed in Excel. Statistical analysis was carried 
out in Graphpad Prism, which was also used to generate the graphs. Data shown in Figs. 2, 3, 7 and 8 represent 
pooled data from two experiments while Figs. 5 and 6 contain data pooled from 3 experiments. Each experiment 
contained similar numbers of wild type and knockin animals. Data was not pooed from multiple experiments 
for Figs. 1 and 4. Data is presented as mean and standard deviation with symbols representing individual mice. 
Significance between the wild type and SIK knockout conditions was assessed by either un-paired two tailed 
Student’s t-test or repeated measures (RM) two-way ANOVA with Sidak’s post hoc testing as indicated in the 
figure legends.
Table 1.  Flow cytometry antibodies.
Antibody Supplier Fluorophore Clone number Dilution
Anti-Thy1.2 BioLegend APC 53–2.1 1:200
Anti-CD4 BioLegend PerCP-Cy5.5 GK1.5 1:200
Anti-CD8 BioLegend PE/Cy-7 53–6.7 1:200
Anti-CD3ε BioLegend FITC 145–2C11 1:50
Anti-CD19 BD Pharmingen APC/Cy7 1D3 1:100
Anti-CD44 BD pharmingen PE IM7 1:100
Anti-CD62L BioLegend BV421 MEL-14 1:100
Anti-TCRβ BioLegend FITC H57-597 1:50
Anti-CD25 BioLegend APC/Cy7 PC61 1:100
Anti-CD2 BioLegend PE RM2-5 1:100
Anti-CD5 eBiosciences PE/Cy5 53–7.3 1:100
Anti-CD5 Biolegend APC 53–7.3 1:50
Anti-FoxP3 eBiosciences PE FJK-16 s 1:100
Anti-CD21 BD Pharmingen FITC 7G6 1:200
Anti-IgM Biolegend PerCP-Cy5.5 RMM-1 1:300
Anti-IgM BD Pharmingen APC II/41 1:200
Anti-Cleaved caspase 3 Cell signaling technology PE D3E9 1:50
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